MGLMX
Price
$16.63
Change
+$0.05 (+0.30%)
Updated
Dec 3 closing price
Net Assets
2.2B
SREAX
Price
$13.82
Change
+$0.02 (+0.14%)
Updated
Dec 3 closing price
Net Assets
215.68M
Interact to see
Advertisement

MGLMX vs SREAX

Header iconMGLMX vs SREAX Comparison
Open Charts MGLMX vs SREAXBanner chart's image
MFS Global Real Estate R4
Price$16.63
Change+$0.05 (+0.30%)
VolumeN/A
Net Assets2.2B
PGIM Select Real Estate A
Price$13.82
Change+$0.02 (+0.14%)
VolumeN/A
Net Assets215.68M
MGLMX vs SREAX Comparison Chart in %
View a ticker or compare two or three
VS
MGLMX vs. SREAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLMX is a Buy and SREAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLMX has more cash in the bank: 2.2B vs. SREAX (216M). MGLMX pays higher dividends than SREAX: MGLMX (2.48) vs SREAX (2.10). MGLMX was incepted earlier than SREAX: MGLMX (11 years) vs SREAX (11 years). SREAX (1.63) is less costly to investors than MGLMX (0.95). SREAX is a more actively managed with annual turnover of: 142.00 vs. MGLMX (48.00). MGLMX has a lower initial minimum investment than SREAX: MGLMX (0) vs SREAX (1000). SREAX annual gain was more profitable for investors over the last year : 1.93 vs. MGLMX (-3.00). SREAX return over 5 years is better than : 18.85 vs. MGLMX (1.78).
MGLMXSREAXMGLMX / SREAX
Total Expense Ratio0.941.3172%
Annual Report Gross Expense Ratio0.951.6358%
Fund Existence11 years11 years-
Gain YTD3.5498.07444%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.2B216M1,018%
Annual Yield % from dividends2.482.10118%
Returns for 1 year-3.001.93-156%
Returns for 3 years2.9926.1211%
Returns for 5 years1.7818.859%
Returns for 10 years24.7461.0041%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPOCX19.270.47
+2.50%
Morgan Stanley Insight L
DTCAX21.060.04
+0.19%
BNY Mellon Sust US Equity A
PCAQX92.620.09
+0.10%
Principal Capital Appreciation R5
IPHYF1.99N/A
N/A
Innate Pharma
PRPRF0.02N/A
N/A
Prairie Provident Resources Inc